Aurobindo Pharma Ltd

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 201903 Annual Report Page No: 147)

Pros:
Company has a good return on equity (ROE) track record: 3 Years ROE 22.63%
Cons:
Company might be capitalizing the interest cost

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019
3,906 3,642 3,679 4,436 4,336 4,049 4,250 4,751 5,270 5,292 5,445 5,600
3,011 2,920 2,845 3,319 3,311 3,261 3,539 3,765 4,183 4,235 4,298 4,460
Operating Profit 895 721 834 1,117 1,026 788 711 986 1,086 1,057 1,146 1,140
OPM % 23% 20% 23% 25% 24% 19% 17% 21% 21% 20% 21% 20%
Other Income 27 42 23 11 33 44 44 -0 41 -4 8 8
Interest 14 14 17 17 19 25 30 35 48 50 50 41
Depreciation 111 100 131 132 138 157 155 164 163 187 241 243
Profit before tax 796 649 709 979 902 651 571 787 917 816 863 864
Tax % 27% 18% 27% 20% 34% 19% 20% 22% 22% 28% 26% 26%
Net Profit 579 532 519 781 595 529 456 611 712 585 636 640
EPS in Rs 9.88 9.10 8.85 13.33 10.16 9.02 7.78 10.44 12.15 9.99 10.85 10.92
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
2,420 3,023 3,515 4,368 4,615 5,842 8,089 12,103 13,772 14,910 16,463 19,564 21,607
2,084 2,850 2,744 3,405 4,050 4,970 5,952 9,524 10,579 11,469 12,691 15,612 17,177
Operating Profit 336 173 772 963 565 873 2,137 2,579 3,193 3,441 3,772 3,952 4,430
OPM % 14% 6% 22% 22% 12% 15% 26% 21% 23% 23% 23% 20% 20%
Other Income 126 170 205 61 -300 17 18 81 200 115 105 70 53
Interest 69 93 73 65 277 267 310 160 257 67 78 263 189
Depreciation 100 128 149 172 201 249 313 333 392 428 558 668 834
Profit before tax 292 122 754 788 -213 374 1,533 2,168 2,744 3,061 3,241 3,091 3,461
Tax % 18% 18% 25% 29% 42% 22% 24% 28% 26% 25% 25% 24%
Net Profit 238 100 563 563 -124 294 1,173 1,576 2,025 2,302 2,423 2,365 2,573
EPS in Rs 4.38 1.79 10.03 9.51 0.00 4.92 19.86 26.55 34.61 38.89 41.36 40.36 43.91
Dividend Payout % 7% 24% 5% 10% -24% 15% 7% 8% 7% 6% 6% 6%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:20.53%
5 Years:19.32%
3 Years:12.41%
TTM:24.27%
Compounded Profit Growth
10 Years:44.66%
5 Years:15.65%
3 Years:6.21%
TTM:19.26%
Stock Price CAGR
10 Years:18.86%
5 Years:-4.98%
3 Years:-17.48%
1 Year:-44.60%
Return on Equity
10 Years:25.10%
5 Years:25.47%
3 Years:22.63%
Last Year:19.01%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
27 27 28 29 29 29 29 29 59 59 59 59 59
Reserves 1,097 1,214 1,801 2,416 2,311 2,577 3,721 5,127 7,229 9,313 11,622 13,832 15,135
Borrowings 1,908 2,333 2,155 2,414 3,096 3,435 3,769 4,451 5,041 3,364 4,770 6,967 5,652
622 652 808 1,013 802 1,375 1,989 3,336 3,613 3,847 5,031 6,026 6,444
Total Liabilities 3,654 4,226 4,791 5,872 6,238 7,416 9,508 12,943 15,941 16,583 21,481 26,884 27,289
1,237 1,399 1,711 1,739 2,195 2,639 2,722 3,706 4,180 4,834 6,521 8,475 9,288
CWIP 278 536 570 657 645 219 310 420 848 1,458 1,583 1,668 1,525
Investments 60 0 0 39 39 22 20 20 123 246 312 360 468
2,079 2,291 2,510 3,438 3,359 4,536 6,457 8,798 10,790 10,046 13,066 16,380 16,009
Total Assets 3,654 4,226 4,791 5,872 6,238 7,416 9,508 12,943 15,941 16,583 21,481 26,884 27,289

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
195 103 427 335 326 275 646 1,237 1,420 3,279 1,955 1,622
-107 -406 -398 -603 -563 -246 -819 -1,017 -1,446 -1,787 -1,927 -2,875
-217 165 -84 407 119 108 118 93 365 -1,915 864 1,919
Net Cash Flow -129 -139 -55 139 -118 137 -55 313 340 -424 892 666

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 12% 5% 22% 20% 8% 11% 27% 27% 27% 25% 23% 18%
Debtor Days 100 107 99 103 98 100 119 107 122 68 68 64
Inventory Turnover 3.34 3.61 3.55 3.42 3.08 3.37 3.77 4.05 3.59 3.56 3.23 2.99

Recent Announcements

View all announcements

Annual Reports

Credit Ratings